CAC
RVMDW icon

Cowen and Company’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Cowen and Company’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-195,600
Closed -$27.4K – 253
2024
Q3 		$27.4K Hold
195,600
– – ﹤0.01% 400
2024
Q2 		$20K Sell
195,600
-4,200
-2% -$870 ﹤0.01% 406
2024
Q1 		$36.5K Sell
199,800
-100
-0.1% -$20 ﹤0.01% 380
2023
Q4 		$66K Buy
+199,900
New +$89.3K ﹤0.01% 260

Other funds holding RVMDW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Soros Capital Management New York $230M AUM 83.9% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Cowen and Company's RVMDW Position: Q4 2024 in Review

Cowen and Company sold out of Revolution Medicines Inc Warrant (RVMDW) in Q4 2024, closing a stake of 195,600 shares — an estimated $27.4K sold.

Cowen and Company first reported a position in RVMDW in Q4 2023 and held it in 4 quarters. The position peaked at $66K in Q4 2023. 24 funds tracked by Wall St. Rank hold RVMDW as of Q4 2024.

  • Cowen and Company reported no remaining Revolution Medicines Inc Warrant position as of Q4 2024 after selling out during the quarter.
  • Cowen and Company sold 195,600 Revolution Medicines Inc Warrant shares in Q4 2024, an estimated $27.4K.
  • Cowen and Company first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and held it in 4 quarters.
  • Cowen and Company's Revolution Medicines Inc Warrant position peaked at $66K in Q4 2023.
  • 24 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q4 2024.

Based on Cowen and Company's 13F filing for Q4 2024.